Smallcap momentum portfolio

Update for entry on 25th November 2024 (lookback dates: 24/11/2023 and 2405/2024)

50EMA (17,587) > 200EMA (16,480); hence, we can continue without any change.

Based on ranking:

1. GVT&D
2. SUVENPHAR
3. DEEPAKFERT
4. JUBLPHARMA
5. NETWEB
6. ANANTRAJ
7. MOTILALOFS
8. DOMS
9. MCX
10. GLENMARK
11. ERIS
12. KAYNES
13. PPLPHARMA
14. VIJAYA
15. ABSLAMC
16. FSL
17. NATIONALUM
18. AMBER
19. JYOTICNC
20. INDIACEM

Based on A → Z for easy tracking:

• ABSLAMC*
• AMBER*
• ANANTRAJ
• DEEPAKFERT
• DOMS
• ERIS
• FSL
• GLENMARK
• GVT&D
• INDIACEM
• JUBLPHARMA
• JYOTICNC*
• KAYNES
• MCX
• MOTILALOFS
• NATIONALUM*
• NETWEB
• PPLPHARMA
• SUVENPHAR
• VIJAYA*

Exits:
HSCL and INOXWIND make an exit.
GODFRYPHLP, NATCOPHARM and POLYMED stay within the top 25 and hence remain.

Entries:
ABSLAMC and VIJAYA make an entry.
AMBER, JYOTICNC and NATIONALUM cannot enter as there is no vacancy.

Note: The above information is provided for educational purposes only. Please consult your Financial advisor before any investment.